Provenienza dei contatti di primo grado di Greg Misson
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Eqalis Pharmaceuticals Ltd
 Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Greg Misson tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| CANNASOUTH LIMITED | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Aspire2 Group Ltd.
 Aspire2 Group Ltd. Miscellaneous Commercial ServicesCommercial Services Aspire2 Group Ltd. provide education and vocational training to domestic, international and business to business students. The firm offers private tertiary education and professional and vocational training. The company is headquartered in Auckland, New Zealand. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
| Nuova-Zelanda | 3 |
Settori
| Health Technology | 2 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 5 |
| Chairman | 1 |
| Independent Dir/Board Member | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Mark Scapens | 3 |
| Hilary Webber | 2 |
| Richard Nash | 1 |
- Borsa valori
- Insiders
- Greg Misson
- Connessioni Società
